Measuring how the opioid crisis affects communities over time
Official title: Measuring the Longer Term Social Burdens of the Opioid Crisis on Local Communities
Funded at Rand Corporation · NIH-11394383 · Data updated 2026-11-12
This NIH grant supports a real-world project to find out how stimulant and opioid problems affect local communities and how best to help treatment programs adopt proven strategies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | August 15, 2018 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $303,289 |
| NIH project number | 5P50DA046351-09 |
| Project ID | NIH-11394383 on NIH RePORTER |
Who could benefit from this research
✓Could help
People receiving opioid use disorder treatment in participating public sector treatment programs who also struggle with stimulant use.
✕Less likely to help
Patients in settings that do not participate in the SSL implementation or who do not have access to contingency management may not benefit.
What this research studies
This project tests a practical approach in real clinics to see how well a multi-level plan called the Science to Service Laboratory helps addiction treatment programs implement contingency management for stimulant use alongside medication for opioid use disorder. It uses a stepped-wedge design to introduce the strategy across 12–15 public OTPs and tracks outcomes across families, health and social functioning. The goal is to identify barriers and facilitators to implementing effective treatments so communities can reduce overdoses and related harms.
Why it matters
Potential benefit: If successful, the work could improve how addiction treatment programs implement effective interventions, potentially lowering overdose risk and improving outcomes for people with opioid and stimulant use disorders.
How similar studies have gone: Prior research supports contingency management as an effective tool for stimulant use, and implementation science approaches have shown promise for scaling up treatments in real-world settings.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Peet, Evan David — Rand Corporation
- Study coordinator: Peet, Evan David
Related research
Other NIH-funded projects on the same topics.
-
Incentives and Anchoring to Improve Long-term HIV Medication Adherence
A study tests a simple, daily habit plan combined with friendly reminders and small rewards to help people living with HIV take their ART pills on time.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
-
Game Changers for cervical cancer prevention in Uganda
A community-based program helps women who have been screened share knowledge to encourage more women to get screened for cervical cancer in Uganda.
-
Game Changers for Cervical Cancer Prevention in Uganda
A program using peer-led group sessions in Uganda aims to help more women get screened for cervical cancer using a low-cost method.
-
Partnering to Build Native American Research Capacity in HEAL Topics
Aimed at helping Tribes and Native American Serving Organizations grow their own NIH-funded research capacity around HEAL topics.
-
Evidence-based alcohol and sexual risk support in homeless young adults
A real-world study will bring a proven counseling approach to drop-in centers serving 18–25-year-olds who are homeless, to help reduce alcohol use and risky sexual behaviors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.